IMMUNOTHERAPY OF COCCIDIOIDOMYCOSIS

被引：49

作者：

CATANZARO, A

SPITLER, L

MOSER, KM

机构：

[1] UNIV CALIF, SCH MED, DEPT MED, PULMONARY DIV, SAN DIEGO, CA 92103 USA

[2] VET ADM HOSP, SAN DIEGO, CA 92037 USA

[3] UNIV CALIF, SCH MED, SAN FRANCISCO, CA 94122 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 1974年 / 54卷 / 03期

关键词：

D O I：

10.1172/JCI107807

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：690 / 701

页数：12

共 22 条

[1] EVALUATION OF TRANSFER FACTOR AS IMMUNOTHERAPY FOR PATIENTS WITH LEPROMATOUS LEPROSY [J].

BULLOCK, WE ;

BRANDRISS, MW ;

FIELDS, JP .

NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (21) :1053-+

[2]

CATANZARO A, 1973, AM REV RESPIR DIS, V107, P1084

[3]

CATANZARO A, IN PRESS

[4]

Fiese M.J., 1958, COCCIDIOIDOMYCOSIS

[5] IMMUNOLOGICAL AND CLINICAL IMPROVEMENT OF PROGRESSIVE COCCIDIOIDOMYCOSIS FOLLOWING ADMINISTRATION OF TRANSFER FACTOR [J].

GRAYBILL, JR ;

SILVA, J ;

ALFORD, RH ;

THOR, DE .

CELLULAR IMMUNOLOGY, 1973, 8 (01) :120-135

[6]

GRISCELLI C, 1973, BIOMEDICINE, V18, P220

[7] EFFECT OF TRANSFER FACTOR ON LYMPHOCYTE FUNCTION IN ANERGIC PATIENTS [J].

KIRKPATRICK, CH ;

SMITH, TK ;

RICH, RR .

JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (11) :2948-+

[8] TRANSFER IN HUMANS OF DELAYED SKIN SENSITIVITY TO STREPTOCOCCAL-M SUBSTANCE AND TO TUBERCULIN WITH DISRUPTED LEUCOCYTES [J].

LAWRENCE, HS .

JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (02) :219-230

[9]

LAWRENCE HS, 1969, ADV IMMUNOL, V11, P169

[10] TRANSFER FACTOR THERAPY IN IMMUNE DEFICIENCY STATES [J].

LEVIN, AS ;

SPITLER, LE ;

FUDENBERG, HH .

ANNUAL REVIEW OF MEDICINE, 1973, 24 :175-208

← 1 2 3 →